{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:24:36Z","timestamp":1793348676585,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":4525,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s13311-011-0025-5","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T04:30:03Z","timestamp":1299558603000},"page":"274-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Latest Approaches for the Treatment of Spasticity and Autonomic Dysreflexia in Chronic Spinal Cord Injury"],"prefix":"10.1016","volume":"8","author":[{"given":"Alexander G.","family":"Rabchevsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Kitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-011-0025-5_bib1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1089\/neu.2004.21.1371","article-title":"Targeting recovery: priorities of the spinal cord-injured population","volume":"21","author":"Anderson","year":"2004","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-011-0025-5_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.expneurol.2005.10.005","article-title":"Changes in vesicular glutamate transporter 2, vesicular GABA transporter and vesicular acetylcholine transporter labeling of sacrocaudal motoneurons in the spastic rat","volume":"197","author":"Kitzman","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.sc.3100867","article-title":"Autonomic dysreflexia","volume":"37","author":"Karlsson","year":"1999","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0079-6123(05)52017-X","article-title":"Segmental organization of spinal reflexes mediating autonomic dysreflexia after spinal cord injury","volume":"152","author":"Rabchevsky","year":"2006","journal-title":"Prog Brain Res"},{"key":"10.1007\/s13311-011-0025-5_bib5","first-page":"1","article-title":"Autonomic dysreflexia in traumatic myelopathy","volume":"59","author":"Kewalramani","year":"1980","journal-title":"Am J Phys Med"},{"key":"10.1007\/s13311-011-0025-5_bib6","series-title":"Clinical autonomic disorders","first-page":"455","article-title":"Autonomic disorders associated with spinal cord injury","author":"Harati","year":"1997"},{"key":"10.1007\/s13311-011-0025-5_bib7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/089771503767869944","article-title":"Autonomic dysreflexia in acute spinal cord injury: an under-recognized clinical entity","volume":"20","author":"Krassioukov","year":"2003","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-011-0025-5_bib8","first-page":"327","article-title":"Autonomic hyperreflexia during cystoscopy in patients with high spinal cord injuries","volume":"15","author":"Snow","year":"1978","journal-title":"Paraplegia"},{"key":"10.1007\/s13311-011-0025-5_bib9","first-page":"931","article-title":"Rehabilitation medicine: 1. Autonomic dysreflexia","volume":"169","author":"Blackmer","year":"2003","journal-title":"CMAJ"},{"issue":"suppl 1","key":"10.1007\/s13311-011-0025-5_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1468-1331.2006.01444.x","article-title":"Management of spasticity in adults: practical application of botulinum toxin","volume":"13","author":"Pathak","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib11","first-page":"401","article-title":"Managing spasticity with drugs","volume":"46","author":"Simon","year":"2010","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1007\/s13311-011-0025-5_bib12","first-page":"722","article-title":"Baclofen","volume":"34","author":"Young","year":"1977","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib13","first-page":"96","article-title":"Drug therapy: spasticity (second of two parts)","volume":"304","author":"Young","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0025-5_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0006-8993(01)02293-4","article-title":"Baclofen inhibition of dorsal root-evoked inhibitory postsynaptic currents in substantia gelatinosa neurons of rat spinal cord slice","volume":"900","author":"Yang","year":"2001","journal-title":"Brain Res"},{"key":"10.1007\/s13311-011-0025-5_bib15","doi-asserted-by":"crossref","unstructured":"Abbruzzese G. The medical management of spasticity. Eur J Neurol 2002;(9 suppl 1):30\u201334; discussion 53\u201361.","DOI":"10.1046\/j.1468-1331.2002.0090s1030.x"},{"key":"10.1007\/s13311-011-0025-5_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1047-9651(18)30033-0","article-title":"Principles of pharmaceutical management of spastic hypertonia","volume":"12","author":"Elovic","year":"2001","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1007\/s13311-011-0025-5_bib17","first-page":"349","article-title":"Psychological and emotional effects of the use of oral baclofen: a preliminary study","volume":"32","author":"Jamous","year":"1994","journal-title":"Paraplegia"},{"key":"10.1007\/s13311-011-0025-5_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10790268.1999.11719570","article-title":"Treatment alternatives for spinal cord injury related spasticity","volume":"22","author":"Kirshblum","year":"1999","journal-title":"J Spinal Cord Med"},{"key":"10.1007\/s13311-011-0025-5_bib19","doi-asserted-by":"crossref","unstructured":"Taricco M, Adone R, Pagliacci C, Telaro E. Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database Syst Rev 2000; Issue 2. Art. No.: CD001131. 10.1002\/14651858.CD001131.","DOI":"10.1002\/14651858.CD001131"},{"key":"10.1007\/s13311-011-0025-5_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.sc.3101178","article-title":"Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia","volume":"39","author":"Burns","year":"2001","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","article-title":"Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study","volume":"78","author":"Coffey","year":"1993","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-011-0025-5_bib22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1047-9651(18)30039-1","article-title":"Intrathecal baclofen therapy for spastic hypertonia","volume":"12","author":"Ivanhoe","year":"2001","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1007\/s13311-011-0025-5_bib23","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/jnnp.2003.014282","article-title":"Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin","volume":"75","author":"Zahavi","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-011-0025-5_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.rehab.2009.09.005","article-title":"Drug treatments for spasticity","volume":"52","author":"Yelnik","year":"2009","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1007\/s13311-011-0025-5_bib25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.sc.3101471","article-title":"Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance\u2013a case report and review of literature","volume":"41","author":"Soni","year":"2003","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/apmr.2002.32820","article-title":"Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome","volume":"83","author":"Coffey","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1007\/s13311-011-0025-5_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0306-4522(90)90311-Q","article-title":"Concomitant depression of locus coeruleus neurons and of flexor reflexes by an alpha 2-adrenergic agonist in rats: a possible mechanism for an alpha 2-mediated muscle relaxation","volume":"34","author":"Palmeri","year":"1990","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-011-0025-5_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-199753030-00007","article-title":"Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders","volume":"53","author":"Wagstaff","year":"1997","journal-title":"Drugs"},{"issue":"24 suppl","key":"10.1007\/s13311-011-0025-5_bib29","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1097\/00007632-200112151-00024","article-title":"Pain and spasticity after spinal cord injury: mechanisms and treatment","volume":"26","author":"Burchiel","year":"2001","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1007\/s13311-011-0025-5_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003495-200059030-00006","article-title":"Drugs used to treat spasticity","volume":"59","author":"Kita","year":"2000","journal-title":"Drugs"},{"key":"10.1007\/s13311-011-0025-5_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1743-0003-7-29","article-title":"Quantification of the effects of an alpha-2 adrenergic agonist on reflex properties in spinal cord injury using a system identification technique","volume":"7","author":"Mirbagheri","year":"2010","journal-title":"J Neuroeng Rehabil"},{"issue":"suppl 4","key":"10.1007\/s13311-011-0025-5_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","article-title":"The structure and mode of action of different botulinum toxins","volume":"13","author":"Dolly","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"issue":"suppl 1","key":"10.1007\/s13311-011-0025-5_bib34","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1046\/j.1526-4610.43.7s.4.x","article-title":"Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins","volume":"43","author":"Dolly","year":"2003","journal-title":"Headache"},{"key":"10.1007\/s13311-011-0025-5_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1098\/rstb.1999.0377","article-title":"Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses","volume":"354","author":"Pellizzari","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"suppl 1","key":"10.1007\/s13311-011-0025-5_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007816","article-title":"Pharmacology and immunology of botulinum toxin serotypes","volume":"248","author":"Aoki","year":"2001","journal-title":"J Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.50.6.682","article-title":"Gabapentin as an antiepileptic drug in man","volume":"50","author":"Crawford","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-011-0025-5_bib38","doi-asserted-by":"crossref","unstructured":"Levendoglu F, Ogun CO, Ozerbil O, Ogun TC, Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine (Phila Pa 1976). 2004;29:743\u2013751.","DOI":"10.1097\/01.BRS.0000112068.16108.3A"},{"key":"10.1007\/s13311-011-0025-5_bib39","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","article-title":"Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain","volume":"159","author":"Morello","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1007\/s13311-011-0025-5_bib40","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"10.1007\/s13311-011-0025-5_bib41","first-page":"470","article-title":"Gabapentin. Pfizer","volume":"3","author":"Wheeler","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1007\/s13311-011-0025-5_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1471-4159.2005.03263.x","article-title":"Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate","volume":"94","author":"Coderre","year":"2005","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-011-0025-5_bib43","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1471-4159.2006.04304.x","article-title":"A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain","volume":"100","author":"Coderre","year":"2007","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-011-0025-5_bib44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/sj.bjp.0705579","article-title":"Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat","volume":"141","author":"Maneuf","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-011-0025-5_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bjp.0704227","article-title":"Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase","volume":"134","author":"Maneuf","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-011-0025-5_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0304-3959(99)00283-3","article-title":"Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn","volume":"85","author":"Shimoyama","year":"2000","journal-title":"Pain"},{"key":"10.1007\/s13311-011-0025-5_bib47","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1523\/JNEUROSCI.2700-10.2010","article-title":"The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2","volume":"30","author":"Tran-Van-Minh","year":"2010","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-011-0025-5_bib48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.sc.3100481","article-title":"Gabapentin for the treatment of spasticity in patients with spinal cord injury","volume":"35","author":"Gruenthal","year":"1997","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.sc.3100366","article-title":"Effectiveness of gabapentin in controlling spasticity: a quantitative study","volume":"35","author":"Priebe","year":"1997","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib50","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0025-5_bib51","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1007\/s13311-011-0025-5_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0028-3908(01)00172-1","article-title":"Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex","volume":"42","author":"Fink","year":"2002","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-011-0025-5_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B","article-title":"3-substituted GABA analogs with central nervous system activity: a review","volume":"19","author":"Bryans","year":"1999","journal-title":"Med Res Rev"},{"key":"10.1007\/s13311-011-0025-5_bib54","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1080\/09638280701602392","article-title":"Pregabalin in the treatment of spasticity: a retrospective case series","volume":"30","author":"Bradley","year":"2008","journal-title":"Disabil Rehabil"},{"key":"10.1007\/s13311-011-0025-5_bib55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.pa.19.040179.002531","article-title":"Molecular mechanisms in the receptor action of benzodiazepines","volume":"19","author":"Costa","year":"1979","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1007\/s13311-011-0025-5_bib56","first-page":"41","article-title":"Clonidine in spinal cord injury","volume":"133","author":"Nance","year":"1985","journal-title":"Can Med Assoc J"},{"key":"10.1007\/s13311-011-0025-5_bib57","first-page":"296","article-title":"Reflex changes induced by clonidine in spinal cord injured patients","volume":"27","author":"Nance","year":"1989","journal-title":"Paraplegia"},{"key":"10.1007\/s13311-011-0025-5_bib58","first-page":"362","article-title":"Mechanism of control of skeletal-muscle contraction by dantrolene sodium","volume":"55","author":"Ellis","year":"1974","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1007\/s13311-011-0025-5_bib59","first-page":"296","article-title":"Clinical pharmaco\u2013physiology of dantrolene sodium","volume":"51","author":"Herman","year":"1972","journal-title":"Am J Phys Med"},{"key":"10.1007\/s13311-011-0025-5_bib60","first-page":"123","article-title":"Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease","volume":"221","author":"Weiser","year":"1978","journal-title":"Practitioner"},{"key":"10.1007\/s13311-011-0025-5_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0269215509353254","article-title":"Rehabilitation in practice: spasticity management","volume":"24","author":"Stevenson","year":"2010","journal-title":"Clin Rehabil"},{"key":"10.1007\/s13311-011-0025-5_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1007\/s13311-011-0025-5_bib63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bjp.0707003","article-title":"Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors","volume":"150","author":"Pryce","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-011-0025-5_bib64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2377-9-59","article-title":"Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review","volume":"9","author":"Lakhan","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib65","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.sc.3101982","article-title":"The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury","volume":"45","author":"Hagenbach","year":"2007","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/TCRM.S5974","article-title":"New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids","volume":"6","author":"Smith","year":"2010","journal-title":"Ther Clin Risk Manag"},{"issue":"5 Pt 2","key":"10.1007\/s13311-011-0025-5_bib67","first-page":"H2077","article-title":"Episodic hypertension due to autonomic dysreflexia in acute and chronic spinal cord-injured rats","volume":"268","author":"Krassioukov","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1007\/s13311-011-0025-5_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/nau.1930140207","article-title":"Autonomic dysreflexia in a rat model spinal cord injury and the effect of pharmacologic agents","volume":"14","author":"Rivas","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"10.1007\/s13311-011-0025-5_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/neu.1998.15.365","article-title":"Relationship between severity of spinal cord injury and abnormalities in neurogenic cardiovascular control in conscious rats","volume":"15","author":"Maiorov","year":"1998","journal-title":"J Neurotrauma"},{"issue":"2 Pt 2","key":"10.1007\/s13311-011-0025-5_bib70","first-page":"H625","article-title":"Relationship between sympathetic activity and arterial pressure in conscious spinal rats","volume":"272","author":"Maiorov","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1007\/s13311-011-0025-5_bib71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/cne.21771","article-title":"Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection","volume":"509","author":"Hou","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0306-4522(95)00294-S","article-title":"Morphological changes in sympathetic preganglionic neurons after spinal cord injury in rats","volume":"70","author":"Krassioukov","year":"1996","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-011-0025-5_bib73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(97)00622-2","article-title":"Sprouting of primary afferent fibers after spinal cord transection in the rat","volume":"85","author":"Krenz","year":"1998","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-011-0025-5_bib74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(98)00101-3","article-title":"Changes in the morphology of sympathetic preganglionic neurons parallel the development of autonomic dysreflexia after spinal cord injury in rats","volume":"243","author":"Krenz","year":"1998","journal-title":"Neuroscience letters"},{"key":"10.1007\/s13311-011-0025-5_bib75","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1152\/jn.2000.83.5.2699","article-title":"Ongoing and stimulus-evoked activity of sympathetically correlated neurons in the intermediate zone and dorsal horn of acutely spinalized rats","volume":"83","author":"Chau","year":"2000","journal-title":"Journal of neurophysiology"},{"key":"10.1007\/s13311-011-0025-5_bib76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2340\/165019771986127132","article-title":"Cutaneous vasomotor sensitivity to noradrenalin in spinal and intact man","volume":"18","author":"Stjernberg","year":"1986","journal-title":"Scand J Rehabil Med"},{"issue":"3 Pt 2","key":"10.1007\/s13311-011-0025-5_bib77","first-page":"H1266","article-title":"Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats","volume":"273","author":"Maiorov","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1007\/s13311-011-0025-5_bib78","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1523\/JNEUROSCI.4390-05.2006","article-title":"Genetic manipulation of intraspinal plasticity after spinal cord injury alters the severity of autonomic dysreflexia","volume":"26","author":"Cameron","year":"2006","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-011-0025-5_bib79","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1523\/JNEUROSCI.19-17-07405.1999","article-title":"Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury","volume":"19","author":"Krenz","year":"1999","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-011-0025-5_bib80","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1089\/089771502762300201","article-title":"Neutralizing intraspinal nerve growth factor with a trkA-IgG fusion protein blocks the development of autonomic dysreflexia in a clip-compression model of spinal cord injury","volume":"19","author":"Marsh","year":"2002","journal-title":"J Neurotrauma"},{"issue":"suppl 1","key":"10.1007\/s13311-011-0025-5_bib81","first-page":"S67","article-title":"Acute management of autonomic dysreflexia: individuals with spinal cord injury presenting to health-care facilities","volume":"25","author":"Medicine","year":"2002","journal-title":"J Spinal Cord Med"},{"key":"10.1007\/s13311-011-0025-5_bib82","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/BF00877117","article-title":"Mechanisms of action of nitrates","volume":"8","author":"Torfgard","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1007\/s13311-011-0025-5_bib83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10790268.1995.11719383","article-title":"Autonomic dysreflexia revisited","volume":"18","author":"Lee","year":"1995","journal-title":"J Spinal Cord Med"},{"key":"10.1007\/s13311-011-0025-5_bib84","first-page":"308","article-title":"Effect of nifedipine on cystometry-induced elevation of blood pressure in patients with a reflex urinary bladder after a high level spinal cord injury","volume":"32","author":"Thyberg","year":"1994","journal-title":"Paraplegia"},{"key":"10.1007\/s13311-011-0025-5_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00002060-199110000-00002","article-title":"Autonomic dysreflexia. A survey of current treatment","volume":"70","author":"Braddom","year":"1991","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1007\/s13311-011-0025-5_bib86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-5347(17)34884-X","article-title":"Prospective evaluation of terazosin for the treatment of autonomic dysreflexia","volume":"151","author":"Chancellor","year":"1994","journal-title":"J Urol"},{"key":"10.1007\/s13311-011-0025-5_bib87","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.sc.3100680","article-title":"Pathophysiology of autonomic dysreflexia: long-term treatment with terazosin in adult and paediatric spinal cord injury patients manifesting recurrent dysreflexic episodes","volume":"36","author":"Vaidyanathan","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01819662","article-title":"A study of the alpha-1 adrenoceptor blocker prazosin in the prophylactic management of autonomic dysreflexia in high spinal cord injury patients","volume":"2","author":"Krum","year":"1992","journal-title":"Clin Auton Res"},{"key":"10.1007\/s13311-011-0025-5_bib89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01827469","article-title":"Contribution of alpha- and beta- adrenoceptors and neuropeptide-Y to autonomic dysreflexia","volume":"5","author":"Santajuliana","year":"1995","journal-title":"Clin Auton Res"},{"issue":"4 Pt 2","key":"10.1007\/s13311-011-0025-5_bib90","first-page":"H1090","article-title":"Does postsynaptic alpha 1-adrenergic receptor supersensitivity contribute to autonomic dysreflexia?","volume":"274","author":"Landrum","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1007\/s13311-011-0025-5_bib91","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1517\/14656566.8.7.945","article-title":"Recognition and effective management of autonomic dysreflexia in spinal cord injuries","volume":"8","author":"Khastgir","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1007\/s13311-011-0025-5_bib92","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/01477447-20090502-07","article-title":"Pharmacological management of hemodynamic complications following spinal cord injury","volume":"32","author":"McMahon","year":"2009","journal-title":"Orthopedics"},{"key":"10.1007\/s13311-011-0025-5_bib93","first-page":"355","article-title":"Autonomic dysreflexia: pharmacological management of hypertensive crises in spinal cord injured patients","volume":"20","author":"Naftchi","year":"1997","journal-title":"J Spinal Cord Med"},{"key":"10.1007\/s13311-011-0025-5_bib94","first-page":"275","article-title":"Vascular dysfunctions following spinal cord injury","volume":"3","author":"Popa","year":"2010","journal-title":"J Med Life"},{"key":"10.1007\/s13311-011-0025-5_bib95","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.expneurol.2006.10.008","article-title":"VGLUT1 and GLYT2 labeling of sacrocaudal motoneurons in the spinal cord injured spastic rat","volume":"204","author":"Kitzman","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-011-0025-5_bib96","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuroscience.2007.07.020","article-title":"Gabapentin suppresses spasticity in the spinal cord-injured rat","volume":"149","author":"Kitzman","year":"2007","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-011-0025-5_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sc.2010.67","article-title":"Gabapentin for spasticity & autonomic dysreflexia after severe spinal cord injury","volume":"49","author":"Rabchevsky","year":"2011","journal-title":"Spinal Cord"},{"key":"10.1007\/s13311-011-0025-5_bib98","first-page":"A","article-title":"Effects of chronic versus acute gabapentin administration on spasticity & autonomic dysreflexia after severe spinal cord injury","volume":"26","author":"Rabchevsky","year":"2010","journal-title":"J Neurotrauma"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-011-0025-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0025-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:03:52Z","timestamp":1761807832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923015416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1878747923015416"],"URL":"https:\/\/doi.org\/10.1007\/s13311-011-0025-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latest Approaches for the Treatment of Spasticity and Autonomic Dysreflexia in Chronic Spinal Cord Injury","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-011-0025-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}